Opaleye Management’s Audentes Therapeutics, Inc BOLD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-292,000
| Closed | -$17.5M | – | 56 |
|
|
2019
Q4 | $17.5M | Buy |
292,000
+7,000
| +2% | +$419K | 3.43% | 10 |
|
|
2019
Q3 | $8.01M | Buy |
285,000
+5,000
| +2% | +$140K | 2.9% | 13 |
|
|
2019
Q2 | $10.6M | Hold |
280,000
| – | – | 3.23% | 11 |
|
|
2019
Q1 | $10.9M | Buy |
280,000
+30,000
| +12% | +$1.17M | 3.03% | 9 |
|
|
2018
Q4 | $5.33M | Buy |
250,000
+25,000
| +11% | +$533K | 1.99% | 19 |
|
|
2018
Q3 | $8.91M | Buy |
225,000
+35,000
| +18% | +$1.39M | 2.27% | 11 |
|
|
2018
Q2 | $7.26M | Hold |
190,000
| – | – | 1.88% | 18 |
|
|
2018
Q1 | $5.71M | Sell |
190,000
-20,000
| -10% | -$601K | 1.63% | 19 |
|
|
2017
Q4 | $6.65M | Buy |
210,000
+30,000
| +17% | +$950K | 2.13% | 14 |
|
|
2017
Q3 | $5.04M | Buy |
180,000
+30,000
| +20% | +$840K | 1.78% | 19 |
|
|
2017
Q2 | $2.87M | Buy |
+150,000
| New | +$2.87M | 1.2% | 23 |
|